| 3R principles | replacement reduction and refinement (animal testing) |
| AAV | adeno-associated virus |
| AI | acceptable intake |
| BE | blood establishment |
| BET | bacterial endotoxin test |
| BSP | Biological Standardisation Programme |
| BWP | Biologics Working Party |
| CAP | centrally authorised product |
| CAS number | Chemical Abstracts Service Registry number |
| CD-P-COS | European Committee for Cosmetics and Consumer Health |
| CD-P-MCA | European Committee for Food Contact Materials and Articles |
| CD-P-PH | European Committee on Pharmaceuticals and Pharmaceutical Care |
| CD-P-PH/CMED | Committee of Experts on Minimising the Public Health Risks Posed by Falsification of Medical Products and Similar Crimes |
| CD-P-PH/PC | Committee of Experts on Quality and Safety Standards in Pharmaceutical Practices and Pharmaceutical Care |
| CD-P-PH/PHO | Committee of Experts on the Classification of Medicines as Regards their Supply |
| CD-P-TO | European Committee on Organ Transplantation |
| CD-P-TS | European Committee on Blood Transfusion |
| CEP | Certificate of Suitability to the European Pharmacopoeia monographs |
| CLEN | Customs Laboratories European Network |
| COVAX | COVID-19 Vaccines Global Access initiative |
| CPCA | Carcinogenic Potency Categorization Approach |
| DCP | decentralised procedure |
| DEG | diethylene glycol |
| EA | European Co-operation for Accreditation |
| EAHP | European Association of Hospital Pharmacists |
| EAT | Enhanced Ames Test |
| ECBS | Expert Committee on Biological Standardization |
| ECDC | European Centre for Disease Prevention and Control |
| ECSPP | Expert Committee on Specifications for Pharmaceutical Preparations (WHO) |
| EDD | European Donation Day |
| EDQM | European Directorate for the Quality of Medicines & HealthCare |
| EEA | European Economic Area |
| EEBA | European Eye Bank Association |
| EFSA | European Food Safety Authority |
| EG | ethylene glycol |
| EMA | European Medicines Agency |
| EPAA | European Partnership for Alternative Approaches to Animal Testing |
| EPC | European Pharmacopoeia Commission |
| EQAAS | External Quality Assurance Assessment Scheme |
| ESCP | European Society of Clinical Pharmacy |
| EU | European Union |
| EUNDB | European Union Network Data Board |
| EuPFI | European Paediatric Formulation Initiative |
| EXS | Excipients Strategy Working Party |
| FIP | International Pharmaceutical Federation |
| FRC | functionality-related characteristics |
| GEON | General European OMCL Network |
| GMP | good manufacturing practice |
| GPGs | Good Practice Guidelines |
| GTMP | gene therapy medicinal product |
| GTWG | Gene Therapy Products Working Group |
| HMA | Heads of Medicines Agencies |
| HMPC | Committee on Herbal Medicinal Products |
| ICH | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use |
| ICRS | International Chemical Reference Substance |
| IMWP | International Meeting of World Pharmacopoeias |
| IPC | Indian Pharmacopoeia Commission |
| IPRP | International Pharmaceutical Regulators Program |
| ISA | International Standards for Antibiotics |
| ISO | International Organization for Standardization |
| ISO/TC | ISO technical committee |
| IVMP | immunological veterinary medicinal product |
| IWP | Immunologicals Working Party |
| JP | Japanese Pharmacopoeia |
| LC-MS/MS | liquid chromatography with tandem mass spectrometry |
| MAT | monocyte-activation test |
| MFDS | South-Korean Ministry of Food and Drug Safety |
| MiRCA | Microbiological Risk of Contamination Assessment |
| MJA | Mutual Joint Audit |
| MJV | Mutual Joint Visit |
| MRP | Mutual Recognition Procedure |
| MSS | market surveillance study |
| MSSIP | market surveillance study on suspected illegal products |
| NAT | nucleic amplification technique |
| NCA | national competent authority |
| NDEA | N-nitrosodiethylamine |
| NDMA | N-nitrosodimethylamine |
| NDSRI | nitrosamine drug substance-related impurity |
| NETTA | Network of National Focal Points on Travel for Transplantation |
| NFP | national focal point |
| NISG | Nitrosamines International Strategic Group |
| NPA | national pharmacopoeia authority |
| OBPR | Official Batch Protocol Review |
| OCABR | Official Control Authority Batch Release |
| OCCL | official cosmetics control laboratory |
| OECD | Organisation for Economic Co-operation and Development |
| OMCL | official medicines control laboratory |
| ONT | Organización Nacional de Trasplantes (Spanish National Transplant Organisation) |
| PCNE | Pharmaceutical Care Network Europe |
| PDCO | Paediatric Committee (EMA) |
| PDG | Pharmacopoeial Discussion Group |
| PEMSAC | Platform of European Market Surveillance Authorities for Cosmetics |
| Ph. Eur. | European Pharmacopoeia |
| PM RA | Post-marketing risk assessment |
| PTS | Proficiency Testing Scheme |
| QDG | Quality Discussion Group |
| QM | quality management |
| QMS | quality management system |
| QWP | Quality Working Party |
| RA | risk assessment |
| RITTA | Registry of International Travel for Transplantation Activity |
| RS | reference standard |
| RTEMIS | Real-Time Remote Inspection System |
| SARM | selective androgen receptor modulator |
| SDS | safety data sheet |
| SEEHN | South-eastern European Health Network |
| SoHO | substance of human origin |
| SUP | suspicious unknown product |
| TFDA | Taiwan Food and Drug Administration |
| TSE | transmissible spongiform encephalopathy |
| UNODC | United Nations Office on Drugs and Crime |
| USP | United States Pharmacopeia |
| VBRN | Veterinary Batch Release Network |
| VICH | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Veterinary Use |
| WG | working group |
| WGQM | Working Group of Quality Managers |
| WHO | World Health Organization |
| WP | working party |
